Sign in

CIK 0001093557

  • Large accelerated filer
Ticker
DXCM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330857544
Phone
+1 858-200-0200
Business address
6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
  1. 4 Grant or award Director acquired 1,054 shares (grant or award)
  2. 4 Grant or award Director acquired 918 shares (grant or award)
  3. 4 Grant or award Director acquired 910 shares (grant or award)
  4. 4 Grant or award Director acquired 918 shares (grant or award)
  5. 4 Grant or award Director acquired 910 shares (grant or award)
  6. 4 Open-market sale Chairman, CEO & President sold 5,535 shares at an average $379.88 ($2,102,626)
  7. 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $415.83 ($207,915)
  8. 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $410.31 ($442,727)
  9. 4 Open-market sale EVP, Global Revenue sold 758 shares at $400.00 ($303,200)
  10. 4 Open-market sale Chairman, CEO & President sold 6,221 shares at an average $366.67 ($2,281,082)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $350.00 ($175,000)
  15. 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $360.49 ($388,967)
  16. 4 Open-market sale EVP Chief Commercial Officer sold 1,109 shares at an average $360.49 ($399,788)
  17. 4 Open-market sale SVP, Finance & CAO sold 941 shares at $362.92 ($341,505)
  18. 4 Open-market sale SVP Information Technology sold 4,567 shares at an average $360.03 ($1,644,267)
  19. 4 Open-market sale Chairman, CEO & President sold 14,044 shares at $362.92 ($5,096,806)
  20. 4 Open-market sale EVP Strategy and Corporate Dev sold 5,566 shares at $362.92 ($2,019,996)

Page 21 of 93 · 1,848 filings